Papers

7

Total Citations

81

H-Index

5

About

Dr. Sara Al-Madhi is a pioneering surgeon whose work is reshaping the landscape of minimally invasive liver and pancreatic surgery, with a particular focus on the transformative potential of robotic platforms. Her research systematically addresses the critical question of whether robotic surgery offers tangible advantages over conventional laparoscopic approaches. In a highly cited 2022 meta-analysis (22 citations), she demonstrated that robotic liver surgery can enhance R0 resection rates for malignancies, a pivotal finding for oncologic outcomes. Dr. Al-Madhi is also a leader in surgical education; her "Robotic Curriculum for young Surgeons" (RoCS) study (10 citations) proves that structured robotic training can be safely integrated into clinical practice without compromising patient outcomes, directly addressing a key barrier to technology adoption. Her work on the LiMAx test (20 citations) provides objective criteria for patient selection, aiming to reduce the risk of post-hepatectomy liver failure. With over 80 citations across her portfolio, including a landmark learning curve analysis of 100 robotic liver resections, Dr. Al-Madhi is not only advancing technical frontiers but also building the evidence base and training infrastructure necessary to make robotic surgery a safe, standard option for patients worldwide.

Research Focus

Key Achievements

5
H-Index
7
Papers
81
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
Does Robotic Liver Surgery Enhance R0 Results in Liver Malignancies during Minimally Invasive Liver Surgery?—A Systematic Review and Meta-Analysis
22 citations · 2022
📈 Most Prolific Year: 2022 (3 Papers)
🤝 Key Collaborators: 25
🏛 Institutions: University Hospital Magdeburg, Otto-von-Guericke University Magdeburg

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago